Gene: PLAUR
Official Full Name: plasminogen activator, urokinase receptorprovided by HGNC
Gene Summary: This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01934 | PLAUR Knockout cell line (HeLa) | Human | PLAUR | 1:3~1:6 | Negative | Online Inquiry |
KO01935 | PLAUR Knockout cell line (HCT 116) | Human | PLAUR | 1:2~1:4 | Negative | Online Inquiry |
KO01936 | PLAUR Knockout cell line (HEK293) | Human | PLAUR | 1:3~1:6 | Negative | Online Inquiry |
KO01937 | PLAUR Knockout cell line (A549) | Human | PLAUR | 1:3~1:4 | Negative | Online Inquiry |
PLAUR Gene Knockout Cell Lines are genetically engineered cell lines designed to study the role of the PLAUR gene, which encodes the urokinase-type plasminogen activator receptor (uPAR). This receptor plays a critical role in various physiological and pathological processes, including cell migration, tumor invasion, and immune response regulation. By providing a knockout model, these cell lines facilitate the exploration of PLAUR's functions by eliminating its expression, thus allowing researchers to investigate the downstream effects on cellular behavior and signaling pathways.
The mechanism of action for these knockout cell lines involves the targeted disruption of the PLAUR gene using CRISPR-Cas9 technology, which introduces precise mutations that lead to a loss of functional receptor expression. This enables a deeper understanding of how uPAR influences various biological processes, particularly in cancer metastasis and wound healing, potentially guiding therapeutic strategies and biomarker development.
The scientific significance of PLAUR Gene Knockout Cell Lines lies in their broad applications in both fundamental research and clinical investigations. By utilizing these models, scientists can elucidate the pathways involved in disease progression and identify novel drug targets, thus expediting translational research. Additionally, their use in pharmacological studies allows for the screening of therapeutic compounds aimed at modulating the effects of uPAR.
One of the key advantages of our PLAUR Gene Knockout Cell Lines compared to conventional models is the specificity and precision of genetic modification, which minimizes off-target effects and enhances experimental reproducibility. Furthermore, our cell lines are well characterized and validated, ensuring reliability in results and saving researchers time in their studies.
Researchers and clinicians looking to advance their understanding of cancer biology, regenerative medicine, or immunology will find significant value in our PLAUR Gene Knockout Cell Lines. These models not only provide essential insight into the role of uPAR but also lay the groundwork for novel therapeutic interventions.
At [Your Company Name], we are committed to providing high-quality biological products backed by our extensive expertise in genetic engineering and cell biology. Our goal is to empower scientists in their quest for knowledge and innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.